Global Pharmaceutical Packaging Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2031 |
 Marktgröße (Basisjahr) | USD 111.52 Billion |
 Marktgröße (Prognosejahr) | USD 192.66 Billion |
 CAGR |
% |
| Wichtige Marktteilnehmer |
|
Global Pharmaceutical Packaging Market, By Product (Primary Packaging, Secondary and Tertiary Packaging), Material (Plastics & Polymers, Paper and Paperboards, Glass, Metals, and Others), Drug Delivery Mode (Oral Drug Delivery Packaging, Parenteral Drug Delivery Packaging, Topical Drug Delivery Packaging, Inhalation Drug Delivery Packaging, Nasal Drug Delivery Packaging, Ocular Drug Delivery Packaging, Other Drugs Delivery Packaging), End User (Pharma Manufacturing Companies, Contract Packaging Companies, Pharmacies, and Others) - Industry Trends and Forecast to 2031 .
Pharmaceutical Packaging Market Analysis and Insights
Outsourcing contract packaging services has become crucial for pharmaceutical companies, enabling them to focus on core competencies while meeting demanding standards. Prespack offers multidimensional partnerships, relieving manufacturers of medicinal products or medical devices from many processes. This trend reflects the growing pharmaceutical outsourcing sector, ultimately contributing to the expansion of the pharmaceutical packaging market.
Data Bridge Market Research analyzes that the global pharmaceutical packaging market is expected to reach USD 192.66 billion by 2031 from USD 111.52 billion in 2023, growing at a CAGR of 7.2% in the forecast period of 2024 to 2031.
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016–2021) |
|
Quantitative Units |
Revenue in USD Billion |
|
Segments Covered |
Product (Primary Packaging, Secondary and Tertiary Packaging), Material (Plastics & Polymers, Paper and Paperboards, Glass, Metals, and Others), Drug Delivery Mode (Oral Drug Delivery Packaging, Parenteral Drug Delivery Packaging, Topical Drug Delivery Packaging, Inhalation Drug Delivery Packaging, Nasal Drug Delivery Packaging, Ocular Drug Delivery Packaging, Other Drugs Delivery Packaging), End User (Pharma Manufacturing Companies, Contract Packaging Companies, Pharmacies, and Others) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, U.K., France, Italy, Netherlands, Spain, Russia, Switzerland, Turkey, Belgium, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, U.A.E., Saudi Arabia, Egypt, Israel, Rest of Middle East and Africa |
|
Market Players Covered |
WestRock Company, Amcor plc, BD, AptarGroup, Inc., West Pharmaceutical Services, Inc., Berry Global , Inc., CCL Industries, Gerresheimer AG, Schott AG, UFlex Limited, SGD Pharma, EPL Limited, Drug Plastics Group, Comar, and Daikyo Seiko Co., Ltd., among others |
Market Definition
Pharmaceutical packaging involves the process of enclosing medications and other pharmaceutical products in packaging materials that ensure their protection, identification, and information dissemination. These materials include plastics, glass, aluminum, paper, and cardboard, each chosen for its specific properties and application. These materials are carefully selected based on their compatibility with the pharmaceutical product, their ability to protect against external factors, and regulatory requirements.
Global Pharmaceutical Packaging Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Rising Pharmaceutical Outsourcing
Pharmaceutical companies are increasingly opting to outsource manufacturing processes to specialized contract packagers. This strategic shift allows these companies to concentrate on their core competencies such as research, development, and marketing, while leaving the complexities of packaging to experts. Contract packagers offer a range of services including packaging design, materials selection, and ensuring compliance with stringent regulatory requirements. This is particularly advantageous for pharmaceutical firms seeking innovative and customized packaging solutions for their products.
- Evolving Role of Pharmaceutical Packaging in Market Differentiation
Packaging has evolved beyond its traditional role of merely containing pharmaceutical products; it is now a key element in differentiating these products in the market. This shift is driven by the intensifying competition in the pharmaceutical industry, where companies are leveraging packaging as a tool to set their products apart from competitors. Packaging serves as a visual and informational platform that communicates vital details about the product, including its quality, safety, and efficacy. Additionally, packaging acts as a marketing medium, helping to attract consumers and influence their purchasing decisions. In response to this trend, there has been a surge in innovative packaging solutions. For example, smart packaging incorporates digital features like RFID tags or QR codes, enabling consumers to access additional product information or track authenticity.
The use of eco-friendly materials in packaging is gaining traction, reflecting consumers' growing environmental consciousness. These innovative approaches not only differentiate products but also contribute to sustainable practices, further enhancing brand reputation.
The focus on product differentiation through packaging is driving significant advancements in the pharmaceutical packaging industry, fostering a market environment ripe for continuous innovation and improvement.
Opportunity
- Innovations in Smart Packaging
Innovations in smart packaging, such as temperature-sensitive labels and RFID tracking, are revolutionizing the global pharmaceutical packaging market. These advancements offer a myriad of benefits, starting with enhanced visibility across the supply chain. Temperature-sensitive labels, for instance, provide real-time monitoring, ensuring medications are stored and transported under optimal conditions. This capability is particularly crucial for pharmaceuticals, as maintaining the right temperature is critical for preserving their efficacy and safety. Moreover, RFID tracking enables companies to track individual product units, ensuring authenticity and preventing tampering. This level of traceability not only helps in compliance with regulatory standards but also boosts consumer trust. Additionally, smart packaging facilitates efficient recall processes, as companies can quickly identify and retrieve affected products.
Restraints/Challenges
- Counterfeiting and Product Security
Counterfeiting in the pharmaceutical sector poses a multifaceted challenge despite the advancements in packaging technologies. The proliferation of counterfeit drugs not only jeopardizes patient health but also erodes trust in pharmaceutical products and the industry. These illicit activities often involve sophisticated tactics, including the replication of packaging and labeling to mimic genuine products. As counterfeiters continually evolve their methods to evade detection, pharmaceutical companies must remain vigilant and adapt their packaging strategies to stay ahead of these threats. This ongoing battle against counterfeit drugs underscores the critical importance of innovative packaging solutions and collaborative efforts within the industry and regulatory bodies to ensure the safety and integrity of pharmaceutical products.
- Cost Constraints for Implementing Advanced Packaging Technologies
The development and implementation of advanced packaging technologies, such as smart packaging and anti-counterfeiting measures, often require substantial investment in research, development, and technology infrastructure. For smaller companies with limited resources, these costs can be prohibitive, preventing them from adopting innovative packaging solutions. As a result, these companies may be at a disadvantage compared to larger competitors who can afford to invest in advanced packaging technologies. This constraint hinder the overall growth and innovation potential of the pharmaceutical packaging market, limiting the availability of advanced packaging solutions and potentially hindering market competitiveness.
Recent Developments
- In September 2023, WestRock Company WRK and Smurfit Kappa Group Plc SMFKY have agreed to merge and create Smurfit WestRock, which is expected to be one of the world’s largest paper and packaging company with a worth of around $20 billion
- In July 2023, Constantia Flexibles has announced its latest pharmaceutical packaging solution, the coldform foil REGULA CIRC, a cutting-edge technology that sets a new standard for sustainability in blister packaging. Designed with circularity in mind, REGULA CIRC complies with future regulations and legislation, offering a total barrier solution that meets the highest sustainable packaging standards
- In June 2022, Berlin Packaging, a one of world's largest hybrid packaging supplier, announced the acquisition of Andler Packaging Group, a value-added distributor of plastic, glass, and metal containers and closures
- In December 2021, Comar, a premier supplier of custom medical devices and assemblies and specialty packaging solutions, announced today it has acquired Omega Packaging, a manufacturer of injection and blow molded products serving the pharmaceutical, nutraceutical, sports nutrition, and skin care markets
- In April 2022, Amcor, a leader in the design and production of ethical packaging solutions, recently revealed the addition of a new, more environment-friendly High Shield laminate to its line of pharmaceutical packaging
Global Pharmaceutical Packaging Market Scope
The global pharmaceuticals packaging market is segmented into four notable segments based on product, material, drug delivery mode, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Product
- Primary Packaging
- Secondary and Tertiary Packaging
On the basis of product, the market is segmented into primary packaging, and secondary and tertiary packaging.
Material
- Plastics & Polymers
- Paper and Paperboards
- Glass
- Metals
- Others
On the basis of material, the market is segmented into plastics & polymers, paper and paperboards, glass, metals, and others.
Drug Delivery Mode
- Oral Drug Delivery Packaging
- Parenteral Drug Delivery Packaging
- Topical Drug Delivery Packaging
- Inhalation Drug Delivery Packaging
- Nasal Drug Delivery Packaging
- Ocular Drug Delivery Packaging
- Other Drugs Delivery Packaging
On the basis of drug delivery mode, the market is segmented into oral drug delivery packaging, parenteral drug delivery packaging, topical drug delivery packaging, inhalation drug delivery packaging, nasal drug delivery packaging, ocular drug delivery packaging, and other drugs delivery packaging.
End User
- Pharma Manufacturing Companies
- Contract Packaging Companies
- Pharmacies
- Others
On the basis of end user, the market is segmented into pharma manufacturing companies, contract packaging companies, pharmacies, and others.
Global Pharmaceutical Packaging Market Regional Analysis/Insights
The global pharmaceutical packaging market is categorized into four notable segments based on product, material, drug delivery mode, and end user.
The countries covered in this market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Netherlands, Spain, Russia, Switzerland, Turkey, Belgium, rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, U.A.E., Saudi Arabia, Egypt, Israel, and rest of Middle East and Africa.
North America is expected to dominate the global pharmaceutical packaging market due to its advanced healthcare infrastructure, robust regulatory framework, and significant investment in research and development. U.S. is expected to dominate the North America due to its advanced healthcare infrastructure, large pharmaceutical industry, and high demand for innovative packaging solutions. China is expected to dominate in the Asia-Pacific region due to its rapidly expanding pharmaceutical industry, large consumer base, and increasing investments in healthcare infrastructure and packaging technologies. Germany is expected to dominate in the Europe region due to its robust pharmaceutical manufacturing sector, strong regulatory environment, and emphasis on high-quality packaging standards.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Pharmaceutical Packaging Market Share Analysis
The global pharmaceutical packaging market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the major market players operating in the market are WestRock Company, Amcor plc, BD, AptarGroup, Inc., West Pharmaceutical Services, Inc., Berry Global, Inc., CCL Industries, Gerresheimer AG, Schott AG, UFlex Limited, SGD Pharma, EPL Limited, Drug Plastics Group, Comar, and Daikyo Seiko Co., Ltd., among others.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL PHARMACEUTICALS PACKAGING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 GLOBAL PHARMACEUTICALS PACKAGING MARKET : REGULATIONS
5.1 REGULATION IN U.S.:
5.2 REGULATION IN CANADA:
5.3 REGULATION IN EUROPE
5.4 REGULATION IN U.K.:
5.5 REGULATION IN INDIA
5.6 REGULATION IN CHINA
5.7 REGULATION IN UNITED ARAB EMIRATES
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PHARMACEUTICAL OUTSOURCING
6.1.2 GROWING PHARMACEUTICAL INDUSTRY
6.1.3 INCREASING DEMAND FOR PATIENT-FRIENDLY PACKAGING
6.1.4 EVOLVING ROLE OF PHARMACEUTICAL PACKAGING IN MARKET DIFFERENTIATION
6.2 RESTRAINTS
6.2.1 COST CONSTRAINTS FOR IMPLEMENTING ADVANCED PACKAGING TECHNOLOGIES
6.2.2 ENVIRONMENTAL CONCERNS REGARDING THE DISPOSAL OF PLASTIC PACKAGING
6.2.3 IMPACT OF STRINGENT REGULATORY STANDARDS ON PHARMACEUTICAL PACKAGING
6.3 OPPORTUNITIES
6.3.1 INNOVATIONS IN SMART PACKAGING
6.3.2 INCREASING FOCUS ON SUSTAINABILITY
6.3.3 RISE OF E-COMMERCE IN THE PHARMACEUTICAL SECTOR
6.4 CHALLENGES
6.4.1 COUNTERFEITING AND PRODUCT SECURITY
6.4.2 SUPPLY CHAIN VULNERABILITIES
7 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 PRIMARY PACKAGING
7.2.1 BOTTLES
7.2.2 BLISTER PACKS
7.2.3 PARENTERAL CONTAINERS
7.2.4 CAPS & CLOSURES
7.2.5 PREFILLABLE INHALERS
7.2.6 POUCHES
7.2.7 MEDICATION TUBES
7.2.8 OTHERS
7.2.8.1 SYRINGES
7.2.8.2 VIALS & AMPOULES
7.2.8.3 OTHERS
7.3 SECONDARY AND TERTIARY PACKAGING
7.3.1 PAPERBOARD BOXES
7.3.2 CARTONS
7.3.3 SHRINK WRAP
7.3.4 OTHERS
8 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL
8.1 OVERVIEW
8.2 PLASTICS & POLYMERS
8.3 PAPER AND PAPERBOARDS
8.4 GLASS
8.5 METALS
8.6 OTHERS
9 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE
9.1 OVERVIEW
9.2 ORAL DRUG DELIVERY PACKAGING
9.3 PARENTERAL DRUG DELIVERY PACKAGING
9.4 TOPICAL DRUG DELIVERY PACKAGING
9.5 INHALATION DRUG DELIVERY PACKAGING
9.6 NASAL DRUG DELIVERY PACKAGING
9.7 OCULAR DRUG DELIVERY PACKAGING
9.8 OTHER DRUGS DELIVERY PACKAGING
10 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMA MANUFACTURING COMPANIES
10.3 CONTRACT PACKAGING COMPANIES
10.4 PHARMACIES
10.5 OTHERS
11 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA
11.2.3 MEXICO
11.3 EUROPE
11.3.1 GERMANY
11.3.2 U.K.
11.3.3 FRANCE
11.3.4 ITALY
11.3.5 SPAIN
11.3.6 NETHERLANDS
11.3.7 BELGIUM
11.3.8 RUSSIA
11.3.9 TURKEY
11.3.10 SWITZERLAND
11.3.11 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 JAPAN
11.4.3 INDIA
11.4.4 SOUTH KOREA
11.4.5 AUSTRALIA
11.4.6 SINGAPORE
11.4.7 INDONESIA
11.4.8 THAILAND
11.4.9 MALAYSIA
11.4.10 PHILIPPINES
11.4.11 REST OF ASIA-PACIFIC
11.5 SOUTH AMERICA
11.5.1 BRAZIL
11.5.2 ARGENTINA
11.5.3 REST OF SOUTH AMERICA
11.6 MIDDLE EAST AND AFRICA
11.6.1 SOUTH AFRICA
11.6.2 U.A.E.
11.6.3 SAUDI ARABIA
11.6.4 EGYPT
11.6.5 ISRAEL
11.6.6 REST OF MIDDLE EAST AND AFRICA
12 GLOBAL PHARMACEUTICAL PACKAGING MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GLOBAL
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
12.3 COMPANY SHARE ANALYSIS: EUROPE
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 WESTROCK COMPANY
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 AMCOR PLC
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT
14.3 BD
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 APTARGROUP, INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 WEST PHARMACEUTICAL SERVICES, INC.
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 BERRY GLOBAL INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 COMPANY SHARE ANALYSIS
14.6.4 PRODUCT PORTFOLIO
14.6.5 RECENT DEVELOPMENT
14.7 CCL INDUSTRIES
14.7.1 COMPANY SNAPSHOT
14.7.2 COMPANY SHARE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 GERRESHEIMER AG
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 COMPANY SHARE ANALYSIS
14.8.4 PRODUCT PORTFOLIO
14.8.5 RECENT DEVELOPMENT
14.9 COMAR, LLC
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.1 DAIKYO SEIKO LTD.
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 DRUG PLASTICS GROUP
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 EPL LIMITED
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENT
14.13 SCHOTT PHARMA AG & CO. KGAA
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENT
14.14 SGD PHARMA
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENTS
14.15 UFLEX LIMITED
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 PHARMA SECTOR’S GROWTH AT CURRENT PRICES
TABLE 2 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 3 GLOBAL PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 4 GLOBAL PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 5 GLOBAL PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 6 GLOBAL SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 7 GLOBAL SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 8 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 9 GLOBAL PLASTICS & POLYMERS IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 10 GLOBAL PAPER AND PAPERBOARDS IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 11 GLOBAL GLASS IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 12 GLOBAL METALS IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 13 GLOBAL OTHERS IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 14 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 15 GLOBAL ORAL DRUG DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 16 GLOBAL PARENTERAL DRUG DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 17 GLOBAL TOPICAL DRUG DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 18 GLOBAL INHALATION DRUG DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 19 GLOBAL NASAL DRUG DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 20 GLOBAL OCULAR DRUG DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 21 GLOBAL OTHER DRUGS DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 23 GLOBAL PHARMA MANUFACTURING COMPANIES IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 24 GLOBAL CONTRACT PACKAGING COMPANIES IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 25 GLOBAL PHARMACIES IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 26 GLOBAL OTHERS IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 27 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 28 NORTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 29 NORTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 30 NORTH AMERICA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 31 NORTH AMERICA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 32 NORTH AMERICA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 33 NORTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 34 NORTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 35 NORTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 36 U.S. PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 37 U.S. PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 38 U.S. PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 39 U.S. SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 40 U.S. PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 41 U.S. PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 42 U.S. PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 43 CANADA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 44 CANADA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 45 CANADA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 46 CANADA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 47 CANADA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 48 CANADA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 49 CANADA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 50 MEXICO PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 51 MEXICO PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 52 MEXICO PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 53 MEXICO SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 54 MEXICO PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 55 MEXICO PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 56 MEXICO PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 57 EUROPE PHARMACEUTICALS PACKAGING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 58 EUROPE PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 59 EUROPE PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 60 EUROPE PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 61 EUROPE SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 62 EUROPE PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 63 EUROPE PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 64 EUROPE PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 65 GERMANY PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 66 GERMANY PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 67 GERMANY PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 68 GERMANY SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 69 GERMANY PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 70 GERMANY PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 71 GERMANY PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 72 U.K. PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 73 U.K. PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 74 U.K. PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 75 U.K. SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 76 U.K. PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 77 U.K. PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 78 U.K. PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 79 FRANCE PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 80 FRANCE PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 81 FRANCE PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 82 FRANCE SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 83 FRANCE PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 84 FRANCE PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 85 FRANCE PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 86 ITALY PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 87 ITALY PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 88 ITALY PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 89 ITALY SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 90 ITALY PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 91 ITALY PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 92 ITALY PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 93 SPAIN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 94 SPAIN PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 95 SPAIN PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 96 SPAIN SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 97 SPAIN PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 98 SPAIN PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 99 SPAIN PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 100 NETHERLANDS PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 101 NETHERLANDS PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 102 NETHERLANDS PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 103 NETHERLANDS SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 104 NETHERLANDS PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 105 NETHERLANDS PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 106 NETHERLANDS PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 107 BELGIUM PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 108 BELGIUM PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 109 BELGIUM PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 110 BELGIUM SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 111 BELGIUM PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 112 BELGIUM PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 113 BELGIUM PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 114 RUSSIA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 115 RUSSIA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 116 RUSSIA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 117 RUSSIA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 118 RUSSIA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 119 RUSSIA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 120 RUSSIA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 121 TURKEY PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 122 TURKEY PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 123 TURKEY PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 124 TURKEY SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 125 TURKEY PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 126 TURKEY PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 127 TURKEY PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 128 SWITZERLAND PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 129 SWITZERLAND PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 130 SWITZERLAND PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 131 SWITZERLAND SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 132 SWITZERLAND PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 133 SWITZERLAND PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 134 SWITZERLAND PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 135 REST OF EUROPE PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 136 ASIA-PACIFIC PHARMACEUTICALS PACKAGING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 137 ASIA-PACIFIC PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 138 ASIA-PACIFIC PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 139 ASIA-PACIFIC PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 140 ASIA-PACIFIC SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 141 ASIA-PACIFIC PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 142 ASIA-PACIFIC PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 143 ASIA-PACIFIC PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 144 CHINA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 145 CHINA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 146 CHINA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 147 CHINA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 148 CHINA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 149 CHINA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 150 CHINA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 151 JAPAN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 152 JAPAN PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 153 JAPAN PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 154 JAPAN SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 155 JAPAN PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 156 JAPAN PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 157 JAPAN PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 158 INDIA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 159 INDIA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 160 INDIA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 161 INDIA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 162 INDIA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 163 INDIA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 164 INDIA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 165 SOUTH KOREA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 166 SOUTH KOREA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 167 SOUTH KOREA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 168 SOUTH KOREA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 169 SOUTH KOREA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 170 SOUTH KOREA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 171 SOUTH KOREA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 172 AUSTRALIA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 173 AUSTRALIA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 174 AUSTRALIA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 175 AUSTRALIA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 176 AUSTRALIA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 177 AUSTRALIA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 178 AUSTRALIA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 179 SINGAPORE PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 180 SINGAPORE PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 181 SINGAPORE PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 182 SINGAPORE SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 183 SINGAPORE PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 184 SINGAPORE PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 185 SINGAPORE PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 186 INDONESIA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 187 INDONESIA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 188 INDONESIA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 189 INDONESIA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 190 INDONESIA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 191 INDONESIA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 192 INDONESIA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 193 THAILAND PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 194 THAILAND PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 195 THAILAND PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 196 THAILAND SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 197 THAILAND PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 198 THAILAND PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 199 THAILAND PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 200 MALAYSIA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 201 MALAYSIA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 202 MALAYSIA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 203 MALAYSIA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 204 MALAYSIA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 205 MALAYSIA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 206 MALAYSIA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 207 PHILIPPINES PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 208 PHILIPPINES PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 209 PHILIPPINES PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 210 PHILIPPINES SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 211 PHILIPPINES PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 212 PHILIPPINES PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 213 PHILIPPINES PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 214 REST OF ASIA-PACIFIC PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 215 SOUTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 216 SOUTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 217 SOUTH AMERICA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 218 SOUTH AMERICA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 219 SOUTH AMERICA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 220 SOUTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 221 SOUTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 222 SOUTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 223 BRAZIL PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 224 BRAZIL PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 225 BRAZIL PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 226 BRAZIL SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 227 BRAZIL PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 228 BRAZIL PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 229 BRAZIL PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 230 ARGENTINA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 231 ARGENTINA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 232 ARGENTINA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 233 ARGENTINA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 234 ARGENTINA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 235 ARGENTINA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 236 ARGENTINA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 237 REST OF SOUTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 238 MIDDLE EAST AND AFRICA PHARMACEUTICALS PACKAGING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 239 MIDDLE EAST AND AFRICA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 240 MIDDLE EAST AND AFRICA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 241 MIDDLE EAST AND AFRICA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 242 MIDDLE EAST AND AFRICA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 243 MIDDLE EAST AND AFRICA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 244 MIDDLE EAST AND AFRICA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 245 MIDDLE EAST AND AFRICA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 246 SOUTH AFRICA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 247 SOUTH AFRICA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 248 SOUTH AFRICA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 249 SOUTH AFRICA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 250 SOUTH AFRICA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 251 SOUTH AFRICA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 252 SOUTH AFRICA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 253 U.A.E. PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 254 U.A.E. PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 255 U.A.E. PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 256 U.A.E. SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 257 U.A.E. PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 258 U.A.E. PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 259 U.A.E. PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 260 SAUDI ARABIA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 261 SAUDI ARABIA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 262 SAUDI ARABIA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 263 SAUDI ARABIA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 264 SAUDI ARABIA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 265 SAUDI ARABIA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 266 SAUDI ARABIA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 267 EGYPT PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 268 EGYPT PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 269 EGYPT PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 270 EGYPT SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 271 EGYPT PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 272 EGYPT PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 273 EGYPT PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 274 ISRAEL PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 275 ISRAEL PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 276 ISRAEL PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 277 ISRAEL SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 278 ISRAEL PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 279 ISRAEL PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 280 ISRAEL PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 281 REST OF MIDDLE EAST AND AFRICA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
Abbildungsverzeichnis
FIGURE 1 GLOBAL PHARMACEUTICALS PACKAGING MARKET: SEGMENTATION
FIGURE 2 GLOBAL PHARMACEUTICALS PACKAGING MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL PHARMACEUTICALS PACKAGING MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL PHARMACEUTICALS PACKAGING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL PHARMACEUTICALS PACKAGING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL PHARMACEUTICALS PACKAGING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL PHARMACEUTICALS PACKAGING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL PHARMACEUTICALS PACKAGING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL PHARMACEUTICALS PACKAGING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL PHARMACEUTICALS PACKAGING MARKET: SEGMENTATION
FIGURE 11 GROWING PHARMACEUTICAL INDUSTRY IS DRIVING THE GROWTH OF THE GLOBAL PHARMACEUTICALS PACKAGING MARKET FROM 2024 TO 2031
FIGURE 12 THE PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PHARMACEUTICALS PACKAGING MARKET IN 2024 AND 2031
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL PHARMACEUTICALS PACKAGING MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR PHARMACEUTICALS PACKAGING MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL PHARMACEUTICALS PACKAGING MARKET
FIGURE 16 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY PRODUCT, 2023
FIGURE 17 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY PRODUCT, 2024-2031 (USD MILLION)
FIGURE 18 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY PRODUCT, CAGR (2024-2031)
FIGURE 19 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 20 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY MATERIAL, 2023
FIGURE 21 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY MATERIAL, 2024-2031 (USD MILLION)
FIGURE 22 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY MATERIAL, CAGR (2024-2031)
FIGURE 23 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY MATERIAL, LIFELINE CURVE
FIGURE 24 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY DRUG DELIVERY MODE, 2023
FIGURE 25 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY DRUG DELIVERY MODE, 2024-2031 (USD MILLION)
FIGURE 26 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY DRUG DELIVERY MODE, CAGR (2024-2031)
FIGURE 27 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY DRUG DELIVERY MODE, LIFELINE CURVE
FIGURE 28 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY END USER, 2023
FIGURE 29 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 30 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY END USER, CAGR (2024-2031)
FIGURE 31 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY END USER, LIFELINE CURVE
FIGURE 32 GLOBAL PHARMACEUTICAL PACKAGING MARKET: SNAPSHOT (2023)
FIGURE 33 GLOBAL PHARMACEUTICAL PACKAGING MARKET: COMPANY SHARE 2023 (%)
FIGURE 34 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET: COMPANY SHARE 2023 (%)
FIGURE 35 EUROPE PHARMACEUTICAL PACKAGING MARKET: COMPANY SHARE 2023 (%)
FIGURE 36 ASIA-PACIFIC PHARMACEUTICAL PACKAGING MARKET: COMPANY SHARE 2023 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
